Clinical trials of semaglutide and tirzepatide documented yeast infections in 13% of participants, with higher rates in women
DEXA body composition scans at baseline, 12 weeks, and 24 weeks provide objective tissue composition data
Pharmacol Ther
Yes, uniquely among peptides, BPC-157 has demonstrated high stability in gastric environments and is frequently researched orally, specifically for gastrointestinal tract injuries
Benefits Beyond Weight Loss While the primary benefit of GLP-1/GIP receptor agonists is weight loss, these medications offer several other significant health advantages: Improved Glycemic Control : By regulating blood sugar levels, GLP-1/GIP receptor agonists can help prevent the complications associated with diabetes, such as neuropathy, retinopathy, and cardiovascular diseases
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
